Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a new revision tag v3.6.6, replacing the previous v3.6.5. This reflects a maintenance update to the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated to v3.6.5, indicating a small system update.SummaryDifference0.0%

- Check51 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new build. This change does not modify visible content or functionality for users on the study details page.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision number updated from v3.6.2 to v3.6.3, indicating a small software/formatting update rather than a change to the study details or user-facing content. No substantive content changes are indicated.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2. This reflects a system/template update, and no study details or related content seem to be affected.SummaryDifference0.0%

- Check94 days agoChange DetectedUpdates to the study record page include the addition of key attribution details (Craig L Slingluff, Jr and University of Virginia) and new navigation/help links (How to Read a Study Record, Common Questions, How to Join a Study). It also shows changes to status verification labels (Last verified, Last known status was) and a new revision tag (Revision: v3.6.0).SummaryDifference1%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.